Clinical Pharmacokinetics of Gentamicin in Neonates

Gentamicin is a bactericidal aminoglycoside antibiotic, it inhibits the protein synthesis. Gentamicin is active against the majority of aerobic gram-negative bacilli such as Pseudomonas, Klebsiella and Escherichia coli. The gentamicin doses are 3 mg/kg once-daily for preterm newborns < 35 weeks o...

Full description

Bibliographic Details
Main Author: Gian Maria Pacifici
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2017-03-01
Series:International Journal of Pediatrics
Subjects:
Online Access:http://ijp.mums.ac.ir/article_8365_44a262c6a0e188d2e410cf0c8eaf2505.pdf